Catalog |
name |
Description |
price |
R-R-0725 |
Biotin-Insulin Receptor (1142-1153) |
Biotin-insulin receptor (1142-1153) refers to a specific region or sequence within the insulin receptor protein that is responsible for binding to biotin. |
price> |
R-R-0726 |
Biotin-Insulin Receptor (1142-1153), amide |
Biotin-Insulin Receptor (1142-1153), amide refers to a specific peptide sequence derived from the insulin receptor protein that has been modified to have an amide group (-NH2) at its C-terminus. |
price> |
R-R-0728 |
Biotin-Secretin, human |
Biotin-Secretin, human refers to a peptide sequence where biotin is conjugated to the hormone secretin. This modified form of secretin allows for its easy detection, interaction studies, and potential applications in research and therapeutics. |
price> |
R-R-0729 |
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28 |
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28/CAS:143519-58-8 is a modified form of the hormone somatostatin, which is involved in the regulation of various physiological functions such as growth hormone release, insulin and glucagon secretion, and gastrointestinal motility. |
price> |
R-R-0731 |
[pSer5] - Kemptide, Biotinylated |
[pSer5]-Kemptide, Biotinylated is a modified peptide derived from the Kemptide, a synthetic peptide substrate commonly used for studying protein kinase activity. In this modified form, the serine residue at position 5 has been phosphorylated and biotin has been attached to the peptide. This modification allows for the specific study of kinases that phosphorylate serine residues at position 5 and also facilitates the detection of phosphorylated Kemptide through its biotin tag. |
price> |
R-R-0733 |
cyclo (Arg-Gly-Asp-D-Tyr-Val) |
Cyclo(Arg-Gly-Asp-D-Tyr-Val) is a cyclic peptide that contains the amino acid sequence Arginine-Glycine-Aspartic Acid-D-Tyrosine-Valine. This sequence is known to be a ligand for integrins, which are a family of cell surface receptors involved in cell adhesion and signaling. The cyclic structure of the peptide enhances its stability and its ability to bind to integrin receptors, making it valuable in research and drug development related to cell adhesion and migration. |
price> |
R-R-0737 |
[Phe1,Ser2]-TRAP-6 |
[Phe1,Ser2]-TRAP-6 refers to a modified form of TRAP-6, which is a peptide derived from the activated platelet protein thrombin receptor-activating peptide (TRAP). In this modified version, the amino acids at position 1 and 2 have been replaced with phenylalanine (Phe) and serine (Ser) respectively. |
price> |
R-R-0738 |
[Phe4]-Dermorphin (1-4) amide |
[Phe4]-Dermorphin (1-4) amide/CAS:118476-87-2 shows high mu-receptpor affinity, excelent mu-selectivity, and seems to be able to cross the blood-brain barrier. |
price> |
R-R-0739 |
[D-Tyr6, beta-Ala11, Phe13, Nle14]-Bombesin (6-14) |
[D-Tyr6, beta-Ala11, Phe13, Nle14]-Bombesin (6-14)/[D-Tyr6, ß-Ala11, Phe13, Nle14]-Bombesin (6-14) is a universal Bombesin synthetic ligand, binding to all 3 bombesin receptors. Bombesin is a 14-aa peptide originally isolated from the fire-bellied toad. It has two mammalian homologs, neuromedin and Gastrin-Releasing Peptide (GRP). It binds with high affinity to the GRP receptor, a member of the G-protein-coupled receptor family. It stimulates gastrin release from G cells, and acts in the brain to stop eating behavior. Bombesin is also a tumor marker for lung small cell carcinoma, neuroblastoma, pancreatic cancer and gastric cancer. |
price> |
R-R-0740 |
[Tyr38,Phe42,46]-Osteocalcin (38-49) (human) |
[Tyr38,Phe42,46]-Osteocalcin (38-49), human/CAS:129356-77-0 is a modified form of the human osteocalcin, a protein primarily found in bone tissue. In this modified version, the amino acids at positions 38, 42, and 46 have been replaced with tyrosine (Tyr) and phenylalanine (Phe) residues. |
price> |